Big #Pharma (Who is included?)

- US & Europe dominating the sector globally
- Sum Total of Top 5 players M-Cap = #Apple
- M-Cap of these together = 80% of India's GDP!
- Typical Features:
(1) Large Advertising + R&D Budget
(2) High Profit Margins

Syngene ties up with HiMedia Laboratories to
manufacture ELISA test kits for COVID-19

Earlier Zydus Cadila Got Nod For ICMR-NIV Developed ELISA Kit
Company has also delivered the first batch but it was free of cost

#Pharma
#stockstowatch

SUN PHARMA & CIPLA; Nithya Balasubramanian, director of Sanford Bernstein said that she likes Cipla and Sun Pharma in the #pharma space.

India-Drug export up 4% to $7921 mn;RMG Textiles up 91% to $4794 mn;Iron Ore up 47% to $2082 mn; Chemicals up 35% to $9293 mn; all figures for FY 22 upto July 2021
#India #Export #Trade #Rice #IronOre #Pharma #Drugs #Textile

Piramal Enterprises Limited appoints Mr. Puneet Yadu Dalmia as an Additional Director

#PiramalEnterprises #INE140A01024 #PEL #FinancialServices #Pharma #Appointment #IndependentDirector

#Unichem Laboratories gets ANDA
approval for its Aripiprazole Tablets USP USFDA to market a generic version of Abilify Tablets, of Otsuka #Pharma.

It is used for Schizophrenia & Irritability associated with Autistic Disorder. Product will be commercialized from Ghaziabad Plant

Natco #Pharma launches generic of Revlimid in US

Co launches the generic in capsules of 5 mg, 10 mg, 15 mg and 25 mg

Celgene Corp's #Revlimid clocks sales of about $8 bn in US.

Natco Pharma settled a case with Celgene Corp on the patent of the drug for launch in US & Canada

As per the new notification, Govt has proposed registration of Class A category medical devices, thus making these #pharma products registered through an identified online portal established for this purpose

#Pharma lobby seeks fair review before #DCGI deems drugs unusable, writes

#Sensex, #Nifty & #NiftyBank are flat for the week
#Midcap records longest gaining streak since September 2022, up for 10th straight week
Except #energy, all sectoral indices post gains, #Realty & #Pharma top gaining indices
33 Nifty stocks give positive returns, #ApolloHosp, #Hero, M&M, #Titan top gainers

#Pharma stocks see some buying, Dr Reddy’s, Sun, Laurus up over 1% each
New-age cos like #Zomato & #Nykaa see healthy gains on Friday, up 4-8%
4 #Nifty stocks (#BajajAuto, #Britannia, #TaMo, #ApolloHosp) hit 52-week highs today
M&M Fin gains more than 1% to hit 52-week high after strong May biz update

#Pharma products cater to regulated & #generic markets. Pharma #intermediate caters to markets like #CRAMS, #regulated markets

#Ethylene glycol and Di Ethylene Glycol (DEG) can be toxic if there is any contamination to the #pharma grade and if it is consumed beyond the recommended levels

#Government plans amnesty scheme to recover dues from for #pharma companies. Pharma companies may get relief on interest & penalty in overpricing issue via amnesty scheme. Pharma regulator, NPPA has 2,200 cases registered w.r.t overpricing: Sources to CNBC-Awaaz https://t.co/T3PWpWCNch

RT @CNBCTV18News: #CNBCTV18Market | #AxisSecurities is bullish on three #pharma stocks, to which it has assigned 'Buy' ratings and price targets that suggest up to 20% upside.

Here's all that investors need to know ⬇️| @senmeghna #StockMarket
https://t.co/AZlpkAQSEi https://t.co/HdNrnJrKbA

Specialised staffing growth likely to be stagnant for the next 1-2 quarters. BFSI hiring was slow due to #RBI restrictions on unsecured lending. See good #hiring momentum in #manufacturing, #pharma, #engineering & #industrials, says Ramani Dathi of #TeamLease